Skip to main content
Article thumbnail
Location of Repository

Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck

By Eva Henriksson, Elisabeth Kjellén, Bo Baldetorp, Pär-Ola Bendahl, Åke Borg, Eva Brun, Fredrik Mertens, Tomas Ohlsson, Karin Rennstam, Johan Wennerberg and Peter Wahlberg
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2654548
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2001). [Fluorine18] fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck.
    2. (2002). A possible prognostic factor in head and neck cancer.
    3. (1984). Aufdemorte TB: Factors that influence growth of head and neck squamous carcinoma in the soft agar cloning assay. Cancer
    4. (1985). Blijham GH: Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry
    5. (2000). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet
    6. (1995). Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer
    7. (2000). Deoxyglucose uptake by a head and neck squamous carcinoma: influence of changes in proliferative fraction.
    8. (1998). Diaz Gonzalez FJ: Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base. Head & Neck
    9. (1997). Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol
    10. (2007). Estimates of cancer incidence and mortality
    11. (2006). FE: Tumor 18F-FDG incorporation is enhanced by attenuation of P53 function in breast cancer cells in vitro.
    12. (1988). Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer
    13. (2004). Grenman R: Permanent in vitro growth is associated with poor prognosis in head and neck cancer. Acta Otolaryngol
    14. (1987). HC: DNA flow cytometry as a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg
    15. (1993). Hong WK: Head and neck cancer.
    16. (1994). Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res
    17. (1999). Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. Blood
    18. (2006). Kjellstrom JH: Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays.
    19. (2003). KK: Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis
    20. (2005). Lammertsma AA, Lebesque JV: Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer.
    21. (1983). Mills MS: Cloning efficiency. A possible prognostic indicator in squamous cell carcinoma of head and neck. Cancer
    22. (1995). Mitelman F: Complex karyotype with an 11q13 homogeneously staining region in esophageal squamous cell carcinoma. Cancer Genet Cytogenet
    23. (1997). Okamoto N: Analysis of DNA ploidy using fresh frozen tissues of head and neck squamous cell carcinomas. Auris Nasus Larynx
    24. (2003). Pedrazzoli S: 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma.
    25. (2002). SE: FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck
    26. (1989). Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry
    27. (2006). T: [F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.
    28. The clonal assay of head and neck tumor cells: results and clinical correlations.
    29. (1998). VR: Proliferation is associated with 2-deoxy-D-[1-3H]glucose uptake by T47D breast tumour and SW480 and SW620 colonic tumour cells. Nucl Med Biol
    30. (2004). Yeung HW: Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.